Chris Mix has joined Agios as Head of Rare Disease Clinical Development. Dr. Mix joins Agios from Sarepta Therapeutics where he served as Executive Medical Director, Global Development and Head of Clinical Development. In addition to a MD from the University of Massachusetts, Dr. Mix has held positions of increasing related responsibility at Tufts New England Medical Center, Amgen, and Alexion.
The search was successfully led by Tamir Halaban at Westwood & Wilshire.
At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.
Westwood & Wilshire, LLC
Offices in Los Angeles, Silicon Valley, Seattle, and Scottsdale
© Westwood & Wilshire LLC. All Rights Reserved.